Milton Essex Spolka Akcyjna Logo

Milton Essex Spolka Akcyjna

MTN | WAR

Overview

Corporate Details

ISIN(s):
PLMLTNE00013
LEI:
259400QAFDSRLAIDCH26
Country:
Poland
Address:
WARSZAWA ŻOŁNY 42A, 02-815 WARSZAWA
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Milton Essex S.A. is a medical technology company specializing in the development of innovative diagnostic systems that integrate artificial intelligence (AI), optoelectronics, and thermodynamics. The company's core focus is on revolutionizing allergy diagnostics and personalized medicine. Its flagship product, SkinSENS™, offers an automated, non-invasive method for diagnosing skin allergic reactions using hyperspectral imaging. Milton Essex is also expanding into biotechnology and develops other solutions, including the ActiveSCAN™ biometric system and multispectral skin imaging technologies. The company actively engages in research and development, leveraging technology transfer from partnerships, including the military sector, to advance its medical applications and improve patient outcomes.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Milton Essex Spolka Akcyjna. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2024-05-01 22:34
Declaration of Voting Results & Voting Rights Announcements
: Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Nadzwyczajn…
Polish 1.4 KB
2024-03-28 12:44
Post-Annual General Meeting Information
projekty uchwał na NWZA Spółki w dniu 23 kwietnia 2024
Polish 144.8 KB
2024-03-28 12:44
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu Nadzwyczajnego Walnego Zgromadzenia Milton Essex S.A. na …
Polish 653 bytes
2023-09-11 12:50
Investor Presentation
Strategia komercjalizacji Palety Produktowej Med-Tech System SkinSENS(tm) na la…
Polish 574.5 KB
2023-09-11 12:50
Report Publication Announcement
: Przyjęcie strategii komercjalizacji Systemu SkinSENS - Content (PL)
Polish 1.7 KB
2023-08-30 11:04
Registration Form
Decyzja Europejskiego Urzędu Patentowego o udzieleniu patentu Spółce - Content …
Polish 2.6 KB
2023-06-28 12:05
Major Shareholding Notification
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Wa…
Polish 1.5 KB
2023-05-31 17:25
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu ZWZA MIlton Essex SA wraz z projektami uchwał
Polish 511.0 KB
2023-05-31 17:25
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Milton Essex S.A. na dzi…
Polish 719 bytes
2023-05-25 12:58
Regulatory News Service
Kolejny etap procesu certyfikacji produktu SkinSens- Imaging System for in vivo…
Polish 2.2 KB
2023-05-15 18:04
Regulatory News Service
uzyskanie patentu przez Spółkę w Europejskim Urzędzie Patentowym - Content (PL)
Polish 2.6 KB
2023-05-11 16:05
Regulatory News Service
podpisanie umowy licencyjnej z ZURAD SP. z o.o. - Content (PL)
Polish 1.6 KB
2023-02-07 19:15
Regulatory News Service
uzyskanie patentu przez Spółkę w Japonii - Content (PL)
Polish 1.6 KB
2022-12-13 23:56
Regulatory News Service
: uzyskanie możliwości rozpoczęcia badań klinicznych SkinSense - Content (PL)
Polish 1.9 KB
2022-11-10 12:23
Declaration of Voting Results & Voting Rights Announcements
wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Nadzwyczajny…
Polish 1.4 KB

Automate Your Workflow. Get a real-time feed of all Milton Essex Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Milton Essex Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN